This webinar explores how pharma and biotech companies can adopt scalable 3D high content analysis (HCA) to accelerate drug ...
More than 20% of the workload on the world's 500 fastest supercomputers is spent simulating how atoms and molecules move—with applications ranging from material design to identifying drug interactions ...